In this episode, Dr. Thomas Seyfried, a leading metabolic cancer researcher and professor at Boston College, discusses the paradigm shift in cancer research with Dr. Hartman. Dr. Seyfried emphasizes the transition from viewing cancer as a genetic disease to understanding it as a metabolic disorder, highlighting mitochondrial dysfunction and fermentation in cancer cell energy production. They explore the implications of this perspective for treatment, including metabolic therapies and dietary strategies. Dr. Seyfried shares case studies and advocates for personalized treatment plans. The episode underscores the importance of metabolic approaches in improving cancer outcomes and calls for greater acceptance within the medical community.

Resources & Links:

🌐 Dr. Thomas Seyfried – Boston College Faculty Page:bc.edu

📘 Book – Cancer as a Metabolic Disease by Dr. Thomas Seyfried

🌐 Dr. Aaron Hartman – Richmond Functional Medicine:richmondfunctionalmedicine.com

🌐 LinkedIn – Dr. Aaron Hartman:Connect Here

📹 YouTube Channel – Richmond Functional Medicine:Watch Here